Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT02004210
What this trial is testing

Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital
Not applicableLooking for participantsNCT06990659
What this trial is testing

Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

Who this might be right for
Hepato Cellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma
University Hospital, Angers 206
Not applicableStudy completedNCT03338062
What this trial is testing

A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy

Who this might be right for
Liver CancerHepatocellular CarcinomaCholangiocarcinoma
Indiana University 15
Not applicableUnknownNCT03227510
What this trial is testing

MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients

Who this might be right for
Hepatocellular Carcinoma
People's Friendship University of Russia 126
Not applicableLooking for participantsNCT05870969
What this trial is testing

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Who this might be right for
Carcinoma, HepatocellularHepatitis C, ChronicHepatitis B, Chronic+2 more
Ruijin Hospital 20,000
Not applicableActive Not RecruitingNCT07230080
What this trial is testing

Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer

Who this might be right for
HCC - Hepatocellular CarcinomaSBRTTACE+2 more
Nanfang Hospital, Southern Medical University 17
Large-scale testing (Phase 3)UnknownNCT02125396
What this trial is testing

Adjuvant Radiotherapy Comparing TACE for Curative HCC

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 150
Not applicableStudy completedNCT04145141
What this trial is testing

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver CancerCholangiocarcinoma
National Cancer Institute (NCI) 132
Not applicableStudy completedNCT06031129
What this trial is testing

Butorphanol in Pain Following Ablation for Hepatic Tumor

Who this might be right for
Visceral PainMicrowave AblationHepatic Tumor
Bibo Wang 300
Testing effectiveness (Phase 2)Ended earlyNCT00427973
What this trial is testing

AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT05864105
What this trial is testing

PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Biotheus Inc. 35
Large-scale testing (Phase 3)UnknownNCT01655641
What this trial is testing

Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery

Who this might be right for
Gastric CancerPancreatic CancerHepatocellular Cancer+1 more
Tribhuvan University Teaching Hospital, Institute Of Medicine. 118
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)UnknownNCT02767375
What this trial is testing

Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection

Who this might be right for
Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 192
Early research (Phase 1)Study completedNCT00960557
What this trial is testing

Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden

Who this might be right for
Neoplasm Metastasis
Mateon Therapeutics 16
Not applicableStudy completedNCT04627012
What this trial is testing

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAnti-PD1 AntibodyLiver Diseases
Sun Yat-sen University 600
Not applicableUnknownNCT05205629
What this trial is testing

A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaDonafenib
Shanghai Zhongshan Hospital 150
Not applicableStudy completedNCT02722395
What this trial is testing

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

Who this might be right for
Primary Liver CancerMetastatic Liver Cancer From Any Cancer Site
Duke University 5
Not applicableWithdrawnNCT03452553
What this trial is testing

Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin

Who this might be right for
Hepatocellular Carcinoma (HCC)
Boston Scientific Corporation
Not applicableLooking for participantsNCT06877637
What this trial is testing

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Cholangiocarcinoma
Region Skane 150
Next Page